| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Late‐onset neutropenia following rituximab treatment in patients with autoimmune diseases
R. Ríos-Fernandez, M. Gutiérrez-Salmerón, J. Callejas-Rubio, M. Fernández-Pugnaire, N. Ortego-Centeno
sion during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol 2001; 45:208– 16. 5 Yamasaki O, Morizane S, Akiyama H, Iwatsuki K…
sion during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol 2001; 45:208– 16. 5 Yamasaki O, Morizane S, Akiyama H, Iwatsuki K. Tendon destruction induced by Panton–Valentine leukocidin-positive Staphylococcus aureus in a patient with Sézary syndrome. Br J Dermatol 2005; 152:586–7.
Published in
British Journal of Dermatology
|
4
|
5 | 2007 |
Social Media Posts